Listed

Autolus Therapeutics plc

AUTLNasdaqCIK 1730463HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$45.7m, Q2 FY2026
Operating income−$43.8m, Q2 FY2026
Net income−$39.1m, Q2 FY2026
Autolus Therapeutics plc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported10.1Revenue, Q1 FY2024, three months to 2024-03-31$10.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$29.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure9.0Revenue, Q1 FY2025, three months to 2025-03-31$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure20.9Revenue, Q2 FY2025, three months to 2025-06-30$20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure21.2Revenue, Q3 FY2025, three months to 2025-09-30$21.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure24.3Revenue, Q4 FY2025, three months to 2025-12-31$24.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure26.2Revenue, Q1 FY2026, three months to 2026-03-31$26.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure45.7Revenue, Q2 FY2026, three months to 2026-06-30$45.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Cost of revenue$mnot reportednot reported0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure11.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$11.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure18.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$18.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure24.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$24.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure28.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$28.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure25.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$25.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure24.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$24.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure20.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$20.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Research and development$m32.3Research and development, Q3 FY2023, three months to 2023-09-30$32.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure37.5Research and development, Q4 FY2023, three months to 2023-12-31$37.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure30.7Research and development, Q1 FY2024, three months to 2024-03-31$30.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure36.6Research and development, Q2 FY2024, three months to 2024-06-30$36.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure40.3Research and development, Q3 FY2024, three months to 2024-09-30$40.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure30.8Research and development, Q4 FY2024, three months to 2024-12-31$30.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure26.7Research and development, Q1 FY2025, three months to 2025-03-31$26.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure27.4Research and development, Q2 FY2025, three months to 2025-06-30$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure27.9Research and development, Q3 FY2025, three months to 2025-09-30$27.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure35.6Research and development, Q4 FY2025, three months to 2025-12-31$35.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure21.2Research and development, Q1 FY2026, three months to 2026-03-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure27.9Research and development, Q2 FY2026, three months to 2026-06-30$27.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Selling, general and administrative$mnot reportednot reported18.2Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$18.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure21.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$21.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure27.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$27.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure34.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$34.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure29.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$29.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure30.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$30.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure36.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$36.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure35.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$35.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure40.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$40.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure41.2Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$41.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Operating income$m(42.9)Operating income, Q3 FY2023, three months to 2023-09-30−$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure(53.3)Operating income, Q4 FY2023, three months to 2023-12-31−$53.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(38.8)Operating income, Q1 FY2024, three months to 2024-03-31−$38.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure(58.9)Operating income, Q2 FY2024, three months to 2024-06-30−$58.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure(67.9)Operating income, Q3 FY2024, three months to 2024-09-30−$67.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(75.9)Operating income, Q4 FY2024, three months to 2024-12-31−$75.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(65.2)Operating income, Q1 FY2025, three months to 2025-03-31−$65.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(61.2)Operating income, Q2 FY2025, three months to 2025-06-30−$61.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(71.6)Operating income, Q3 FY2025, three months to 2025-09-30−$71.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(72.5)Operating income, Q4 FY2025, three months to 2025-12-31−$72.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(59.5)Operating income, Q1 FY2026, three months to 2026-03-31−$59.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(43.8)Operating income, Q2 FY2026, three months to 2026-06-30−$43.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Interest expense$m5.0Interest expense, Q3 FY2023, three months to 2023-09-30$5.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure30.1Interest expense, Q4 FY2023, three months to 2023-12-31$30.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure19.3Interest expense, Q1 FY2024, three months to 2024-03-31$19.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure10.2Interest expense, Q2 FY2024, three months to 2024-06-30$10.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure10.7Interest expense, Q3 FY2024, three months to 2024-09-30$10.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(30.8)Interest expense, Q4 FY2024, three months to 2024-12-31−$30.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure10.1Interest expense, Q1 FY2025, three months to 2025-03-31$10.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(6.8)Interest expense, Q2 FY2025, three months to 2025-06-30−$6.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure10.5Interest expense, Q3 FY2025, three months to 2025-09-30$10.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure22.8Interest expense, Q4 FY2025, three months to 2025-12-31$22.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure11.1Interest expense, Q1 FY2026, three months to 2026-03-31$11.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(2.7)Interest expense, Q2 FY2026, three months to 2026-06-30−$2.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Income tax$m(0.0)Income tax, Q3 FY2023, three months to 2023-09-30−$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2024, three months to 2024-03-31−$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$51.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$22.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure1.5Income tax, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure2.2Income tax, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure0.4Income tax, Q2 FY2025, three months to 2025-06-30$397.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure0.5Income tax, Q3 FY2025, three months to 2025-09-30$532.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(1.2)Income tax, Q4 FY2025, three months to 2025-12-31−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure0.9Income tax, Q1 FY2026, three months to 2026-03-31$863.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure0.5Income tax, Q2 FY2026, three months to 2026-06-30$465.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Net income$m(45.8)Net income, Q3 FY2023, three months to 2023-09-30−$45.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure(77.2)Net income, Q4 FY2023, three months to 2023-12-31−$77.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(52.7)Net income, Q1 FY2024, three months to 2024-03-31−$52.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure(58.3)Net income, Q2 FY2024, three months to 2024-06-30−$58.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure(82.1)Net income, Q3 FY2024, three months to 2024-09-30−$82.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(27.6)Net income, Q4 FY2024, three months to 2024-12-31−$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(70.2)Net income, Q1 FY2025, three months to 2025-03-31−$70.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(47.9)Net income, Q2 FY2025, three months to 2025-06-30−$47.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(79.1)Net income, Q3 FY2025, three months to 2025-09-30−$79.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure(90.3)Net income, Q4 FY2025, three months to 2025-12-31−$90.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(71.6)Net income, Q1 FY2026, three months to 2026-03-31−$71.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(39.1)Net income, Q2 FY2026, three months to 2026-06-30−$39.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Diluted EPS$ per share(0.26)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure(0.22)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure(0.31)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(0.18)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(0.30)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figurenot reported(0.27)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(0.15)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Basic EPS$ per share(0.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figurenot reported(0.24)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure(0.22)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure(0.31)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figurenot reported(0.26)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(0.18)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure(0.30)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figurenot reported(0.27)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(0.15)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure

Balance sheet

Cash and equivalents$171.4m, Q2 FY2026
Shareholders' equity$74.8m, Q2 FY2026
Autolus Therapeutics plc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m256Cash and equivalents, Q3 FY2023, at 2023-09-30$256.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure240Cash and equivalents, FY2023, at 2023-12-31$239.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001730463-25-000019.Report this figure759Cash and equivalents, Q1 FY2024, at 2024-03-31$758.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure706Cash and equivalents, Q2 FY2024, at 2024-06-30$705.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure657Cash and equivalents, Q3 FY2024, at 2024-09-30$657.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure227Cash and equivalents, FY2024, at 2024-12-31$227.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure95.8Cash and equivalents, Q1 FY2025, at 2025-03-31$95.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure124Cash and equivalents, Q2 FY2025, at 2025-06-30$123.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure86.1Cash and equivalents, Q3 FY2025, at 2025-09-30$86.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure104Cash and equivalents, FY2025, at 2025-12-31$104.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure131Cash and equivalents, Q1 FY2026, at 2026-03-31$130.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure171Cash and equivalents, Q2 FY2026, at 2026-06-30$171.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Current assets$m308Current assets, Q3 FY2023, at 2023-09-30$308.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-03-21, accession 0001730463-24-000048.Report this figure275Current assets, FY2023, at 2023-12-31$275.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001730463-25-000019.Report this figure804Current assets, Q1 FY2024, at 2024-03-31$804.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-17, accession 0001730463-24-000064.Report this figure759Current assets, Q2 FY2024, at 2024-06-30$758.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001730463-24-000093.Report this figure718Current assets, Q3 FY2024, at 2024-09-30$718.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure661Current assets, FY2024, at 2024-12-31$660.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure616Current assets, Q1 FY2025, at 2025-03-31$615.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure574Current assets, Q2 FY2025, at 2025-06-30$574.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure515Current assets, Q3 FY2025, at 2025-09-30$514.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure436Current assets, FY2025, at 2025-12-31$435.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure369Current assets, Q1 FY2026, at 2026-03-31$368.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure336Current assets, Q2 FY2026, at 2026-06-30$336.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Total assets$m406Total assets, Q3 FY2023, at 2023-09-30$406.1m. XBRL concept us-gaap:Assets. 10-K filed 2024-03-21, accession 0001730463-24-000048.Report this figure375Total assets, FY2023, at 2023-12-31$375.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001730463-25-000019.Report this figure901Total assets, Q1 FY2024, at 2024-03-31$901.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-17, accession 0001730463-24-000064.Report this figure854Total assets, Q2 FY2024, at 2024-06-30$853.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001730463-24-000093.Report this figure827Total assets, Q3 FY2024, at 2024-09-30$827.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure783Total assets, FY2024, at 2024-12-31$782.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure746Total assets, Q1 FY2025, at 2025-03-31$746.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure721Total assets, Q2 FY2025, at 2025-06-30$721.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure662Total assets, Q3 FY2025, at 2025-09-30$661.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure589Total assets, FY2025, at 2025-12-31$589.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure527Total assets, Q1 FY2026, at 2026-03-31$527.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure493Total assets, Q2 FY2026, at 2026-06-30$493.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Current liabilities$m37.5Current liabilities, Q3 FY2023, at 2023-09-30$37.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-21, accession 0001730463-24-000048.Report this figure44.7Current liabilities, FY2023, at 2023-12-31$44.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001730463-25-000019.Report this figure44.0Current liabilities, Q1 FY2024, at 2024-03-31$44.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-17, accession 0001730463-24-000064.Report this figure40.9Current liabilities, Q2 FY2024, at 2024-06-30$40.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001730463-24-000093.Report this figure52.5Current liabilities, Q3 FY2024, at 2024-09-30$52.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure60.7Current liabilities, FY2024, at 2024-12-31$60.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure66.6Current liabilities, Q1 FY2025, at 2025-03-31$66.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure68.2Current liabilities, Q2 FY2025, at 2025-06-30$68.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure83.1Current liabilities, Q3 FY2025, at 2025-09-30$83.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure73.4Current liabilities, FY2025, at 2025-12-31$73.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure63.6Current liabilities, Q1 FY2026, at 2026-03-31$63.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure68.8Current liabilities, Q2 FY2026, at 2026-06-30$68.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Total liabilities$m226Total liabilities, Q3 FY2023, at 2023-09-30$225.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-21, accession 0001730463-24-000048.Report this figure264Total liabilities, FY2023, at 2023-12-31$263.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001730463-25-000019.Report this figure319Total liabilities, Q1 FY2024, at 2024-03-31$319.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-17, accession 0001730463-24-000064.Report this figure326Total liabilities, Q2 FY2024, at 2024-06-30$325.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001730463-24-000093.Report this figure351Total liabilities, Q3 FY2024, at 2024-09-30$350.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure355Total liabilities, FY2024, at 2024-12-31$355.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure375Total liabilities, Q1 FY2025, at 2025-03-31$375.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure375Total liabilities, Q2 FY2025, at 2025-06-30$374.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure396Total liabilities, Q3 FY2025, at 2025-09-30$396.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure411Total liabilities, FY2025, at 2025-12-31$410.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure418Total liabilities, Q1 FY2026, at 2026-03-31$418.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure418Total liabilities, Q2 FY2026, at 2026-06-30$418.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m181Shareholders' equity, Q3 FY2023, at 2023-09-30$180.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure111Shareholders' equity, FY2023, at 2023-12-31$111.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001730463-26-000038.Report this figure582Shareholders' equity, Q1 FY2024, at 2024-03-31$582.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure528Shareholders' equity, Q2 FY2024, at 2024-06-30$527.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure477Shareholders' equity, Q3 FY2024, at 2024-09-30$477.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure427Shareholders' equity, FY2024, at 2024-12-31$427.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure371Shareholders' equity, Q1 FY2025, at 2025-03-31$371.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure346Shareholders' equity, Q2 FY2025, at 2025-06-30$346.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure265Shareholders' equity, Q3 FY2025, at 2025-09-30$265.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure178Shareholders' equity, FY2025, at 2025-12-31$178.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure109Shareholders' equity, Q1 FY2026, at 2026-03-31$108.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure74.8Shareholders' equity, Q2 FY2026, at 2026-06-30$74.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure

Cash flow

Operating cash flow−$25.1m, Q2 FY2026
Capital expenditure$913.0k, Q2 FY2026
Autolus Therapeutics plc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(40.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$40.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001730463-24-000136. Derived: 9-month figure less the 6-month figure.Report this figure(24.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$24.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(40.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$40.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure(51.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$51.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001730463-25-000067. Derived: 6-month figure less the 3-month figure.Report this figure(76.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$76.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001730463-25-000088. Derived: 9-month figure less the 6-month figure.Report this figure(37.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$37.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(75.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$75.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(72.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$72.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001730463-26-000123. Derived: 6-month figure less the 3-month figure.Report this figure(67.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$67.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001730463-25-000088. Derived: 9-month figure less the 6-month figure.Report this figure(67.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$67.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(65.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$65.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure(25.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$25.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001730463-26-000123. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001730463-24-000136. Derived: 9-month figure less the 6-month figure.Report this figure1.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001730463-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$533.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure0.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$841.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001730463-25-000067. Derived: 6-month figure less the 3-month figure.Report this figure9.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001730463-25-000088. Derived: 9-month figure less the 6-month figure.Report this figure11.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$11.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure8.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$8.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure7.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001730463-26-000123. Derived: 6-month figure less the 3-month figure.Report this figure4.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001730463-25-000088. Derived: 9-month figure less the 6-month figure.Report this figure(0.9)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$885.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001730463-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure2.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$913.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001730463-26-000123. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)266.16m, Q2 FY2026
Autolus Therapeutics plc, shares, quarterly
Line itemUnitperiod not labelled2022-09-30period not labelled2023-03-31period not labelled2023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares91.2Diluted shares (weighted), period not labelled, three months to 2022-09-3091,240,801 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-03-21, accession 0001730463-24-000048.Report this figure174Diluted shares (weighted), period not labelled, three months to 2023-03-31173,825,825 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-17, accession 0001730463-24-000064.Report this figure174Diluted shares (weighted), period not labelled, three months to 2023-06-30173,860,491 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001730463-24-000093.Report this figure174Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30173,984,101 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001730463-24-000136.Report this figure222Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31222,170,707 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001730463-25-000039.Report this figure266Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30266,025,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001730463-25-000067.Report this figure266Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30266,084,589 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure266Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31266,126,548 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure266Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30266,141,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure266Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30266,141,431 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001730463-25-000088.Report this figure266Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31266,143,425 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001730463-26-000065.Report this figure266Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30266,158,829 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure

Shares outstanding: 266.16mShares outstanding, period not labelled, at 2026-08-10266,162,540 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001730463-26-000123.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.